Primary Formulary Changes
August 10, 2023
FDA Grants Accelerated Approval for Elrexfio (elranatamab-bcmm) for Relapsed or Refractory Multiple Myeloma
August 14, 2023
Primary Formulary Changes
August 10, 2023
FDA Grants Accelerated Approval for Elrexfio (elranatamab-bcmm) for Relapsed or Refractory Multiple Myeloma
August 14, 2023

Upcoming Formulary Changes

BeneCard PBF is committed to providing innovative clinical solutions, valuable trend management strategies, and the highest quality of service. We regularly conduct a review of our formulary to remain current with the ever-changing prescription drug landscape.

During this review process, we consider changes that occur with new FDA approvals (brand and generic) and the latest clinical information. This comprehensive review looks at each therapeutic category to identify clinically superior products at the lowest net cost. This process is essential to help control pharmaceutical spend as drug costs, particularly for already costly specialty medications, increase over time. Our goal when considering updates to our formularies is to improve member health outcomes while maximizing plan savings.

October 2023 Changes

The following changes to the Performance Formulary will go into effect on October 1, 2023.

Moved from Excluded to Tier 1 Generic Most Common Indication/Use
GLATOPA Multiple Sclerosis
Moved from Excluded to Preferred Most Common Indication/Use
OVIDREL Infertility
AZSTARYS ADHD
Moved from Excluded to Non-Preferred Most Common Indication/Use
JAYPIRCA Lymphoma
ORSERDU Breast Cancer
FILSPARI Proteinuria
AUSTEDO XR Tardive Dyskinesia
DAYBUE Rett Syndrome
PRADAXA PELLETS Anticoagulant
SKYCLARYS Friedreich’s Ataxia
Moved from Non-Preferred to Excluded Most Common Indication/Use
SUPREP Bowel Prep
XYREM Narcolepsy
Moved from Preferred to Excluded Most Common Indication/Use
DIVIGEL Menopausal Symptoms
NOVAREL Infertility
Moved from Tier 1 Generic to Excluded Most Common Indication/Use
CHORIONIC GONADOTROPIN Infertility

BeneCard PBF appreciates your trust and support in serving your healthcare needs through your pharmacy benefit program. If you have any questions, please contact your BeneCard PBF Account Executive, or call our Client Service Center at 1-877-587-2239.